| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −80.8× | −1.7× | |
| Price / Book | 4.6× | 2.0× | |
| Price / Sales | 2,932.1× | 3.9× | |
| Price / Free cash flow | −31.9× | −1.6× | |
| EV / EBITDA | −87.7× | −1.1× | |
| Earnings yield | −1.2% | −14.6% | |
| Free cash flow yield | −3.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,250.33 | −0.53% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.25 | −0.51% | $612.72B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.61 | −0.28% | $502.94B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.28 | +0.71% | $362.88B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.55 | −0.96% | $356.63B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.56 | −0.04% | $278.52B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.99 | −0.25% | $255.88B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.30 | −1.41% | $251.54B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.56 | −0.91% | $231.69B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.95 | −0.79% | $192.13B | 22.8× | 37.5% | +32.0% |
